The move by the International Auditing and Assurance Standards...
Category:
Regulation
Latest
RBI Guv asks banks to have robust systems to curb digital frauds
Sanjay Malhotra,Governor,RBI While dwelling upon IT risk management...
Sebi launches digital knowledge repository ‘Dharohar’ on Republic Day
It is designed to cater to a wide audience, including students,...
Will RBI joining NGFS help in climate finance?
The 22nd Financial Stability Report (FSR22) of the RBI had, about the “climate-related risk” that the value of financial assets/liabilities could be affected either by continuation in climate change (physical risks), or by an adjustment towards a low-carbon economy (transition risks). The manifestation of physical risks could lead to a sharp fall in asset prices and increase in uncertainty, it said.
Digital currency model likely by the end of year: RBI
Earlier, RBI Governor Shaktikanta Das made it clear that the central bank continues to have concerns with the private digital currency (DCs) which are not regulated and has conveyed the same to the government
RBI keeps policy rate unchanged,raises inflation forecast
“The need of the hour is not to drop our guard and to remain vigilant against any possibility of a third wave especially in the background of rising infections in certain parts of the country,” RBI Governor Shaktikanta Das said in a virtual address accompanying the MPC’s decision.
Sebi board agrees in principle to ‘controlling shareholders’ concept
The board noted that the investor landscape is now changing, with private equity and institutional investors holding significant shareholding in listed companies. ”In recent years, a number of businesses and new-age companies with diversified shareholding and professional management that are coming into the listed space are non-family owned and/or do not have a distinctly identifiable promoter group,” the board said.
Willis Towers mulls sale of reinsurance unit after halting merger
Reports this week suggested Gallagher was close to clinching a deal for Willis Re, but Willis Towers Watson Chief Executive Officer John Haley said he is considering wider possibilities.
“We’re conducting a review of strategic alternatives for Willis Re,” Haley told a conference call on Tuesday reporting on second-quarter results. While the timing was “appropriate” given the failed merger, he warned that a sale was not assured.
Rajya Sabha passes Limited Liability Partnership Amendment Bill to encourage startups
The bill, which was passed after a short debate, seeks to decriminalise 12 offences under the law and help to improve the ease of doing business by amending the Limited Liability Partnership (LLP) Act, 2008.
Pvt hospitals, labs welcome Delhi govt’s announcement on capping of rate of RT-PCR and RATs
Welcoming the decision Dr Bhagwan Mantri, Senior Consultant, Respiratory and Chest Medicine at Moolchand Hospital said, ”RT-PCR tests are required for everything these days – for travel purposes and for hospital admissions. Capping of prices will help people in going for tests and they will not be hesitant. It will also prevent people from going in for fake test reports that are available for Rs 200-300.”
Financial regulators urgently need to get a grip on ‘Big Tech’: BIS
Global watchdogs are increasingly wary that the huge amounts of data controlled by groups such as Facebook, Google, Amazon and Alibaba could allow them to reshape finance so rapidly that it destabilises entire banking systems.
ESG integration in business will help create long-term value: Report
The top five risks of the decade that can majorly impact the society include infectious diseases, climate action failure, weapons of mass destruction, biodiversity loss and natural resource crisis, the report said.
The likelihood of extreme weather, climate action failure, human environmental damage, infectious diseases and biodiversity loss becoming a reality is increasing day by day, it added.
Johnson and Johnson still in discussion with Centre over indemnity issue: Sources
As per the sources, Johnson and Johnson is not going to participate in the trials for the single-dose vaccine in India. They are also having discussions over indemnity with the government.In June, a spokesperson of the company told ANI that as per the recent announcement by the Drugs Controller General of India (DCGI), there is no longer a requirement to conduct bridging clinical studies of COVID-19 vaccines in India.